Literature DB >> 7876386

Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.

M J Hussain1, J Y Lau, R Williams, D Vergani.   

Abstract

AIM: To determine the hepatic expression of tumour necrosis factor-alpha (TNF alpha) in patients with chronic hepatitis B virus (HBV) infection.
METHODS: Frozen liver biopsy sections from 19 patients with chronic HBV infection were studied, 12 of whom were HBeAg positive and 10 serum HBV DNA positive. Hepatic expression of TNF alpha was determined using immunohistochemistry.
RESULTS: Only infiltrating mononuclear cells showed immunoreactive staining for TNF alpha (median 2, range 0-3; n = 19) which appeared as diffuse positive staining material in the cytoplasm. Patients with active liver disease, assessed histologically and biochemically, had a higher level of expression, both in the number of TNF alpha positive cells and the proportion of TNF alpha positive infiltrating mononuclear cells. There was no correlation between the expression of TNF alpha and serological parameters of viral infection (HBeAg and HBV DNA status and HBV DNA concentrations).
CONCLUSION: Hepatic expression of TNF alpha is increased in chronic HBV infection and is related to the activity of liver disease and not to the level of HBV replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876386      PMCID: PMC502205          DOI: 10.1136/jcp.47.12.1112

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Tumour necrosis factor to treat chronic hepatitis B virus infection.

Authors:  N Sheron; J Y Lau; H M Daniels; J Webster; A L Eddleston; G J Alexander; R Williams
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

2.  Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection.

Authors:  N Sheron; J Lau; H Daniels; J Goka; A Eddleston; G J Alexander; R Williams
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

Review 3.  Molecular and cellular pathology of hepatitis B.

Authors:  M A Gerber; S N Thung
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

4.  Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation counting.

Authors:  E A Fagan; P Guarner; S D Perera; R Trowbridge; N Rolando; F Davison; R Williams
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

5.  Human leukocyte antigen class I-independent pathways may contribute to hepatitis B virus-induced liver disease after liver transplantation.

Authors:  G Missale; J J Brems; H Takiff; P J Pockros; F V Chisari
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

6.  Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

Authors:  J Y Lau; G L Bird; N V Naoumov; R Williams
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

7.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.

Authors:  M Mondelli; G M Vergani; A Alberti; D Vergani; B Portmann; A L Eddleston; R Williams
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

9.  Hepatic expression of type A and type B receptors for tumor necrosis factor.

Authors:  R Volpes; J J van den Oord; R De Vos; V J Desmet
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

10.  HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma.

Authors:  P N Gilles; D L Guerrette; R J Ulevitch; R D Schreiber; F V Chisari
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

View more
  6 in total

Review 1.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

2.  Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein.

Authors:  F Su; C N Theodosis; R J Schneider
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 3.  Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.

Authors:  Matthew B Carroll; Michael A Forgione
Journal:  Clin Rheumatol       Date:  2010-06-16       Impact factor: 2.980

Review 4.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 5.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model.

Authors:  Horng-Tay Tzeng; Hwei-Fang Tsai; I-Tsu Chyuan; Hsiu-Jung Liao; Chun-Jen Chen; Pei-Jer Chen; Ping-Ning Hsu
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.